Skip to main content
. 2019 Sep 17;9:13455. doi: 10.1038/s41598-019-49878-4

Figure 7.

Figure 7

Survival analysis of MSI-H vs. MSS in CRC patients stratified by their association with immune checkpoint molecules: (a) PD-1, (b) PD-L1, (c) CTLA4, (d) LAG3 and (e) TIM3. High, high expression of each gene; low, low expression of each gene.